Ex Parte FORSTOVA et al - Page 11



              Appeal No. 1998-0667 Page 11                                                                         
              Application No. 081280,306                                                                           
                    material can be enclosed within an empty pseudocapsid or otherwise                             
                    wrapped up with the capsid antigen.                                                            
              Specification, page 5. 
                                                                             
              These two passages provide a clear objective distinction between the work described in 
             
              Sandig and the present invention. As defined by appellants, the exogenous material 
                 
              associated with the pseudocapsid of claim 29 is protected by the pseudocapsid, i.e., 
               
              "enclosed w~ithin an empty pseudocapsid or otherwise wrapped up with the capsid 
                    
              antigen," while that of Sandig was adsorbed to the pseudocapsid surfaces. 
                          
                    On this record, it is clear that the pseudocapsids described in Sandig relied upon             
              by the examiner do not allow for the transfer of the exogenous material into a host cell             
              so that the materials taken up by the cell is biologically functional in the cell as required        
              by the rejected claims                                                                               
                    The rejection under 35 U.S.C. § 102(b) based upon Sandig is reversed.                          
              3. Obviousness reiections.                                                                           
                    The first obviousness rejection is premised upon the disclosures of Slilaty and                
              Lowy. At page 8 of the Answer, the examiner states that Slilaty describes a method of                
              using polyoma virus pseudocapsids to transfer DNA in the cultured rat cells. However,                
              the pseudocapsids of Slilaty are not composed entirely of major capsid antigen. The                  
              examiner makes note of the teaching in Slilaty that a limitation of the polyoma virus                
              pseudocapsid as a gene transfer agent is its small size which lirr~its the amount of DNA             
              which can be packaged.                                                                               










Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007